• US reported highest ever number of new COVID-19 cases
• Stimulus talks remain deadlocked
• Dunkin’ Brands (DNKN.US) stock soared over 15% on acquisition news
US indices launched the week lower as investors remain concerned about the rising coronavirus infections. The US reported more than 83k new cases on both Friday and Saturday, a new record high. Meanwhile seven-day average on Sunday reached a new daily record of 68,767 cases according to a CNBC analysis of data from Johns Hopkins University. White House chief of staff Mark Meadows acknowledged that the U.S. is not going to control the pandemic. Instead, he pointed to the administration’s focus on a potential vaccine or therapeutic to manage COVID-19, rather than measures to help mitigate the spread. Despite this news, a new aid bill seems very unlikely to happen before next week’s presidential election. House Speaker Nancy Pelosi and Meadows accused each other of “moving the goalposts” in negotiations over the weekend. On the corporate front, the earnings season continues with Apple, Facebook, Alphabet, Amazon, Boeing and Caterpillar all reporting later in the week.
US30 – index broke below the major support at 28 090 pts which is additionally strengthened by 50 SMA (green line). Should downbeat moods prevail, support at 27 408 pts may come into play. However, if buyers will manage to push the price above the aforementioned support, then next potential target for bulls is located at 28344 pts. Source: xStation5
Dunkin’ Brands (DNKN.US) — stock jumped more than 15% in the premarket after the company announced that Inspire Brands, the owner of restaurant chains Arby’s and Jimmy John’s, is interested of acquisition of Dunkin’ Brands. According to The New York Times potential a deal would take Dunkin’ Brands private for $106.50 per share, which would be 20% above the stock’s closing price of $88.79 per share on Friday.
Dunkin’ Brands (DNKN.US) launched today’s session with a massive bullish price gap and is trading at new all-time high, thanks to the news regarding potential acquisition. However, should sellers regain control, then nearest support is located at $84.75. Source: xStation5
AstraZeneca (AZN.US) stock rose 0.8% after the company announced its coronavirus potential vaccine produced a similar immune response in older and younger adults during a clinical trial.
Hasbro (HAS.US) reported better than expected quarterly figures. Toy maker earned $1.88 per share on revenue of $1.78 billion while analysts' were expected earnings of $1.63 per share on revenue of $1.74 billion. However company’s stock fell over 2% due to poor performance of its TV, film and entertainment division.
Facebook (FB.US) — KeyBanc Capital Markets raised its price target on the social media giant to $340 per share, citing an “attractive” valuation. “We believe regulatory concerns have exerted downward pressure on valuation multiples,” KeyBanc said.
This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.